Body composition, metabolic syndrome and testosterone in ageing men
The DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.
Abstract
The ageing process in men is marked by changes in body composition (loss of fat-free mass (FFM) and skeletal muscle, and gain in fat mass (FM)) and is associated with a decline in serum testosterone. Correlations between these aspects of ageing and the acknowledged role of exogenous testosterone in reversing the loss of FFM and gain in FM seen in adult men with congenital or acquired hypoandrogenism have led to the hypothesis that testosterone therapy in ageing men will result in favourable changes in body composition and may improve metabolic status and/or cardiovascular risk. Data from randomized controlled trials of testosterone therapy in ageing men addressing the endpoints of body composition and components of the metabolic syndrome and cardiovascular risk factors are reviewed, and the impact of the increasing prevalence of obesity on these relationships is considered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In males, the testosterone level (including its precursor dehydroepiandrosterone sulfate) declines in aging up to 1% per year from 30.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [52]
In the citing paper
“Aging comes with is a decrease in anabolic hormones such as testosterone and GH.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [52]
In the citing paper
“In women, testosterone also rapidly decreases from 20 to 45 years old.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [52]
In the citing paper
“In obese people, testosterone levels are low [31, 41, 51–53].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [52]
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
Celermajer, D. S., Sorensen, K. E., Gooch, V. M., Spiegelhalter, D. J., Miller, O. I., Sullivan, I. D., Lloyd, J. K., & Deanfield, J. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)93147-f · Cited by 4,742
Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr
Janssen, I., Heymsfield, S. B., Wang, Z., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.1.81 · Cited by 3,087
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Close Relation of Endothelial Function in the Human Coronary and Peripheral Circulations
Anderson, T. J., Uehata, A., Gerhard, M. D., Meredith, I. T., Knab, S., Delagrange, D., Lieberman, E. H., Ganz, P., Creager, M. A., Yeung, A. C., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00327-4 · Cited by 2,033
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Celermajer, D. S., Sorensen, K. E., Spiegelhalter, D. J., Georgakopoulos, D., Robinson, J., & Deanfield, J. E. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90305-0 · Cited by 1,335
Cited by
Sarcopenic obesity: definition, cause and consequences
Stenholm, S., Harris, T. B., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328312c37d · Cited by 1,070
Kelly, D. M., & Jones, T. H. (2015) · Obesity Reviews · doi:10.1111/obr.12282 · Cited by 487
“Indeed, there is a lack of studies of TRT in men that have examined the effects of treatment on VAT or SAT as a function of baseline adiposity and none has examined abdominal fat (visceral, subcutaneous) volumes (see (318)).”
BackgroundKalinchenko, S. Y., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Giltay, E. J., & Saad, F. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03845.x · Cited by 341
Allan, C. A., Strauss, B. J. G., Burger, H. G., Forbes, E. A., & McLachlan, R. I. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1291 · Cited by 298
“mal testosterone levels will modify metabolic and cardiovascular risk is an important one (55).”
BackgroundSelf-citationThe Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile Dysfunction
Traish, A. M., Guay, A., Feeley, R., & Saad, F. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.005215 · Cited by 286
Sarcopenic obesity and endocrinal adaptation with age
Sakuma, K., & Yamaguchi, A. (2013) · International Journal of Endocrinology · doi:10.1155/2013/204164 · Cited by 189
“Similarly, obese individuals tend to have lower testosterone levels [73].”
BackgroundMechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures
Rubio-Ruiz, M. E., Guarner-Lans, V., Pérez-Torres, I., & Soto, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030647 · Cited by 165
“Obese individuals tend to have lower T levels [146].”
BackgroundObesity, low testosterone levels and erectile dysfunction
Diaz‐Arjonilla, M., Schwarcz, M. G., Swerdloff, R. S., & Wang, C. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.42 · Cited by 153
Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Kob, R., Bollheimer, L. C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C. C., & Fischer, B. E. (2015) · Biogerontology · doi:10.1007/s10522-014-9539-7 · Cited by 151
“Levels of this hormone decline with age and are individually influenced by nutrition and physical activity, with a trend towards decreasing in obese men (Sakuma and Yamaguchi 2013; Allan et al. 2007).”
BackgroundInterplay of skeletal muscle and adipose tissue: sarcopenic obesity
Park, M., & Choi, K. M. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155577 · Cited by 150
Hoyos, C. M., Yee, B. J., Phillips, C. L., Machan, E. A., Grunstein, R. R., & Liu, P. Y. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0525 · Cited by 145
Links among Obesity, Type 2 Diabetes Mellitus, and Osteoporosis: Bone as a Target
Martiniaková, M., Bíro, R., Pénzes, N., Šarocká, A., Kováčová, V., Mondočková, V., & Omelka, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094827 · Cited by 119
“…may contribute to bone fragility, as obese men have been shown to have low testosterone levels [133]. obesity-induced hypogonadism may contribute fragility, as obese men have been shown to have low testosterone levels [133 Surprisingly, Premaor et al. [134] demonstrated an unaccountably high (28”
BackgroundThe role of testosterone in the metabolic syndrome: A review
Saad, F., & Gooren, L. J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.022 · Cited by 112
Stenholm, S., Strandberg, T. E., Pitkala, K., Sainio, P., Heliovaara, M., & Koskinen, S. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt052 · Cited by 105
Upadhya, B., Haykowsky, M. J., Eggebeen, J., & Kitzman, D. W. (2015) · Current Heart Failure Reports · doi:10.1007/s11897-015-0257-5 · Cited by 89
Sex Steroid Hormone Levels and Body Composition in Men
Gates, M. A., Mekary, R. A., Chiu, G. R., Ding, E. L., Wittert, G., & de Araújo, A. B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2582 · Cited by 88
“mass and an increase in total and abdominal fat mass (1).”
BackgroundTestosterone Replacement Ameliorates Nonalcoholic Fatty Liver Disease in Castrated Male Rats
Nikolaenko, L., Jia, Y., Wang, C., Diaz-Arjonilla, M., Yee, J. K., French, S. W., Liu, P. Y., Laurel, S., Chong, C., Lee, K., et al. (2014) · Endocrinology · doi:10.1210/en.2013-1648 · Cited by 87
Haider, A., Gooren, L. J. G., Padungtod, P., & Saad, F. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1202774 · Cited by 83
Saad, F., & Gooren, L. J. (2011) · Journal of Obesity · doi:10.1155/2011/471584 · Cited by 82
“[38] C.”
BackgroundAre declining testosterone levels a major risk factor for ill-health in aging men?
Yeap, B. B. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.60 · Cited by 83
The critical role of oxidative stress in sarcopenic obesity
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4493817 · Cited by 79
Androgens, health and sexuality in women and men
Wylie, K. R., REES, M. C. P., Hackett, G. I., Anderson, R. A., Bouloux, P.-M. G., Cust, M., Goldmeier, D., Kell, P. D., TERRY, T. R., TRINICK, T. R., et al. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.07.011 · Cited by 75
Role of androgens in cardiovascular pathology
Chistiakov, D. A., Myasoedova, V. A., Melnichenko, A. А., Grechko, A. V., & Orekhov, A. N. (2018) · Vascular Health and Risk Management · doi:10.2147/vhrm.s173259 · Cited by 70
“Indeed, androgen dysregulation associated with aging generally results in altered lipid metabolism, increased body fat and obesity that represent well-known risk factors of cardiovascular disease, and in many instances, can be attenuated by testosterone replacement therapy.(77) Direct protective effects of testosteron…”
Kim, H.-T., Kim, H.-J., Ahn, H. Y., & Hong, Y. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.156 · Cited by 52
“156 terone [38]; increased levels of interleukin 6 and tumor necrosis factor α [39]; cellular dysfunction and apoptosis with mitochondrial damage [11], and decreased dietary protein intake [13] can be factors contributing to the loss of SMM and strength with aging.”
BackgroundObesity, Bariatric Surgery, and Fractures
Lespessailles, É., Paccou, J., Javier, R., Thomas, T., & Cortet, B. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02084 · Cited by 51
Kelsey, M. M., Harwood, J. E. F., Travers, S. H., Zeitler, P. S., & Nadeau, K. J. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.202 · Cited by 44
Dalmasso, C., Patil, C. N., Cardozo, L. L. Y., Romero, D. G., & Maranon, R. O. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007074 · Cited by 35
“Most studies in hypogonadal men show that testosterone supplements increase lean mass and decrease fat mass.(20,21) Our young males were not hypogonadal when they were treated with testosterone, and this may explain why we did not see an increase in lean mass but did see a reduction in fat mass.”
BackgroundGranado, M., García‐Cáceres, C., Fuente-Martín, E., Díaz, F., Mela, V., Viveros, M., Argente, J., & Chowen, J. A. (2011) · Endocrinology · doi:10.1210/en.2011-1233 · Cited by 32
Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure
Bielecka-Dabrowa, A. M., Fabiś, J., Mikhailidis, D. P., von Haehling, S., Sahebkar, A., Rysz, J., & Banach, M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.003 · Cited by 31
Body Mass Index and risk of frailty in older adults: A systematic review and meta-analysis
Amiri, S., Behnezhad, S., & Hasani, J. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100196 · Cited by 31
Androgens, health and sexuality in women and men
Wylie, K. R., REES, M. C. P., Hackett, G. I., Anderson, R. A., Bouloux, P.-M. G., Cust, M., Goldmeier, D., Kell, P. D., TERRY, T. R., TRINICK, T. R., et al. (2010) · Human Fertility · doi:10.3109/14647273.2010.530966 · Cited by 30
Obesity and Mobility in Advancing Age: Mechanisms and Interventions to Preserve Independent Mobility
Vincent, H. K., & Mathews, A. (2013) · Current Obesity Reports · doi:10.1007/s13679-013-0059-6 · Cited by 27
“Fatty acids suppress growth hormone production and are accompanied by low testosterone [12].”
BackgroundCardiovascular diseases and erectile dysfunction: the two faces of the coin of androgen deficiency
Yassin, A. A., Akhras, F., El‐Sakka, A. I., & Saad, F. (2010) · Andrologia · doi:10.1111/j.1439-0272.2009.01021.x · Cited by 25
Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease
Hagymási, K., Reismann, P., Rácz, K., & Tulassay, Z. (2009) · Orvosi Hetilap · doi:10.1556/oh.2009.28749 · Cited by 23
Guligowska, A., Chrząstek, Z., Pawlikowski, M., Pigłowska, M., Pisarek, H., Winczyk, K., & Kostka, T. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.797243 · Cited by 21
“Numerous studies describe the relationship between testosterone deficiency and decrease in muscle mass and strength, bone mass, and an increase in visceral adipose tissue in older men (40, 41).”
BackgroundJapas, C., Knutsen, S. F., Dehom, S. O., Santos, H. D., & Tonstad, S. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2013.11.007 · Cited by 21
“Testosterone levels decrease from as early as 30 years of age and are correlated with fat-free mass loss and increases in fat mass [16].”
Association Among Metabolic Syndrome, Testosterone Level and Severity of Erectile Dysfunction
Yeh, H., Wang, C., Lee, Y., Hsiao, H., Wu, W., Chou, Y., & Huang, C. (2008) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(08)70148-7 · Cited by 20
“In any case, there is increasing evidence of the beneficial role that androgen replacement therapy plays in decreasing the risk of MS and associated cardiovascular morbidities [38].”
Nutritional Considerations in Preventing Muscle Atrophy
Creţoiu, S. M., & Zugravu, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_23 · Cited by 19
The role of the urologist in the prevention and early detection of cardiovascular disease
Yassin, A. A., Saad, F., Haider, A., & Gooren, L. J. (2011) · Arab Journal of Urology · doi:10.1016/j.aju.2011.03.014 · Cited by 18
“Numerous studies have found inverse associations between the severity of features of the metabolic syndrome and plasma testosterone level [26].”
BackgroundRubinow, K. B., Wang, S., den Hartigh, L. J., Subramanian, S., Morton, G. J., Buaas, F. W., Lamont, D., Gray, N., Braun, R. E., & Page, S. T. (2015) · Andrology · doi:10.1111/andr.12055 · Cited by 16
“Men with low circulating androgen levels exhibit changes in body composition characterized by decreased lean body mass and increased fat mass (Mauras et al., 1998; Pasquali, 2006; Allan et al., 2007).”
Zhu, J., Xiang, Y., Cai, H., Li, H., Gao, Y., Zheng, W., & Shu, X. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.11.015 · Cited by 16
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-388-7:191 · Cited by 13
Mundell, N. L., Owen, P. J., Via, J. D., Macpherson, H., Daly, R. M., Livingston, P. M., Rantalainen, T., Foulkes, S., Millar, J. L., Murphy, D. G., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060189 · Cited by 14
Graybeal, A. J., Willis, J. L., Morales, E., Tinsley, G. M., Messiah, S. E., & Shah, M. (2022) · Nutrition · doi:10.1016/j.nut.2022.111815 · Cited by 12
Slevin, F., Sethugavalar, B., Al‐Qaisieh, B. M., Bownes, P. J., Mason, J., Smith, J. M., Bottomley, D., & Henry, A. M. (2020) · Journal of Contemporary Brachytherapy · doi:10.5114/jcb.2020.101686 · Cited by 12
“It is well-known that with increasing age, sexual function decreases [25].”
BackgroundKim, T. N., & Choi, K. M. (2013) · Journal of Korean Diabetes · doi:10.4093/jkd.2013.14.4.166 · Cited by 11
Берштейн, Л. М., & Kovalenko, I. G. (2010) · Problems of Endocrinology · doi:10.14341/probl201056347-51 · Cited by 10
“Хотя по-прежнему имеется немало сторонников лечения ожирения вне зависимости от его «типовой принадлежности», уже достаточно давно высказывается точка зрения о том, что подобный подход к MHO может оказаться неэффективным и даже контрпродуктивным [8, 10], поскольку, например, на фоне диеты с ограниченной энергетической…”
Windows of opportunity: a holistic approach to men's health*
Holden, C. A., Allan, C. A., & McLachlan, R. I. (2010) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03708.x · Cited by 10
Self-citationGoncharov, N., Katsya, G. V., Gaivoronskaya, L. M., Zoloedov, V. I., Uskov, V. L., & Gooren, L. J. (2012) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2012-0023 · Cited by 10
Hoyos, C. M., Yee, B. J., Phillips, C. L., Cayanan, E. A., Grunstein, R. R., & Liu, P. Y. (2015) · European Journal of Endocrinology · doi:10.1530/eje-12-0525e · Cited by 8
Influence of androgen deficiency on carbohydrate metabolism in men
Mkrtumyan, A. M., & Egshatyan, L. V. (2017) · Obesity and metabolism · doi:10.14341/omet2017319-24 · Cited by 5
Tishova, Y. A., & Kalinchenko, S. Y. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000800021 · Cited by 5
“Also an association between visceral and central obesity and hypogonadism could be established (7,8).”
BackgroundEffect of Androgen Deficiency on the Condition of Carbohydrate Metabolism in Men
Mkrtumyan, A. M., Yegshatyan, L. V., & Shishkova, Y. A. (2020) · Effective Pharmacotherapy · doi:10.33978/2307-3586-2020-16-12-56-66 · Cited by 4
“), установлена обратная связь между окружностью талии (показатель висцерального ожирения) и уровнем тестостерона во всех возрастных группах [6].”
The metabolic syndrome: when is testosterone treatment warranted
Gooren, L. J., Meryn, S., & Shabsigh, R. (2008) · Journal of Men s Health · doi:10.1016/j.jomh.2008.03.012 · Cited by 4
“Numerous studies have found associations between features of the metabolic syndrome and plasma testosterone [8–13].”
Ferreira, J. P., Leal, A. M. O., Vasilceac, F. A., Sartor, C. D., Sacco, I. D. C. N., Soares, A. S., & Salvini, T. F. (2018) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20187394 · Cited by 4
“1590/1414-431X20187394 Brazilian Journal of Medical and Biological Research (2018) 51(9): e7394, http://dx.”
BackgroundGao, J. X., Wang, L. H., Li, W., & Liu, W. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2624183 · Cited by 3
“…hormonal dysregulation through inflammation, insulin resistance, and altered aromatase activity, establishing a self-perpetuating cycle that accelerates testosterone decline [23–25]. decline in spermatogenic function represents another distinctive clinical hallmark of testicular ageing in men.”
Cardiovascular effects of testosterone
Jackson, G. (2008) · Current Sexual Health Reports · doi:10.1007/s11930-008-0033-6 · Cited by 3
Testosterone reducing cardiovascular risk - looks promising but randomised trials needed
Jackson, G. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01839.x · Cited by 2
Miedany, Y. M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87950-1_3 · Cited by 1
Musculoskeletal and immunological considerations
Fettke, G., Kaplan, B., Baker, S., & Rice, S. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821617-0.00004-8 · Cited by 1
A meta‐analysis of Chinese men's penile size in a global context
Wang, C., & Wangding, Y. (2024) · Andrology · doi:10.1111/andr.13727 · Cited by 1
Capítulo V: Factores de riesgo para el desarrollo de diabetes tipo 2 y síndrome metabólico
Palacios, A., Durán, M., & Obregón, O. (2013) · SaberULA (Universidad de Los Andes) · Cited by 1
Zegar, H., & Zaazaa, F. (2021) · Dépôt Institutionnel de lUniversité de Tlemcen · Cited by 1
Male hypogonadism in a patient with Cogan syndrome
Radman, M., Kraus, O., & Solter, M. (2008) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2008.471a · Cited by 1
Quality of life in young men with abdominal obesity depending on androgen deficiency
Каратаева, О. В., Panova, E. I., Жданкина, Н. В., & MOROZOVA, E. P. (2018) · Perm Medical Journal · doi:10.17816/pmj35649-52 · Cited by 1
Blombäck, E. (2013) · DiVA at Umeå University (Umeå University)
Jackson, G. (2009) · doi:10.1093/med/9780199566990.003.1503
Effects of metabolic syndrome on erectile dysfunction
Khan, A. I., Enobakhare, O., Stoddard, M. D., Eidelberg, A., Punjani, N., & Kashanian, J. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819765-3.00014-5
Endocrinopathies, maladies métaboliques et sexualité
Lemaire, A. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.07.013
“[29] Allan CA, Strauss BJG, McLachlan RI.”
Testosterone: A Missing Biological Link in Morbidity and Mortality Among U.S. Veterans
Lipov, E. (2026) · Medical Research Archives · doi:10.18103/mra.v14i5.7507
Herse, M. N. (2020) · NVA (Nasjonalt vitenarkiv)
Theodorakopoulos, C. (2018) · Queen Margaret University Publications Repository (Queen Margaret University)
Medira. Terveyden jäljillä – Turusta maailman turuille
Vuori, H. (. ). (2011) · UTUPub (University of Turku)
The metabolic portrait of obese children
Малявская, С. И., & Лебедев, А. В. (2016) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Peek, C. (2012) · Boloka Institutional Repository (North-west University)
Metadata
- Authors
- Allan, C. A., Strauss, B. J. G., & McLachlan, R. I.
- Affiliations
- Monash Medical Centre (AU)
- Monash University (AU)
- Corresponding author
- McLachlan, R I
- Venue
- International Journal of Impotence Research
- Published
- 2007-06-07
- Volume
- 19
- Issue
- 5
- Pages
- 448-457
- ISSN
- 0955-9930 (ISSN-L)
- 1476-5489
- OpenAlex
- W2000924220
- Cited by
- 67
- References
- 103
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 8 · 2012: 2
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- International Journal of Impotence Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- older men, testosterone replacement therapy, body composition, metabolic syndrome, fat-free mass loss, fat gain, skeletal muscle atrophy, cardiovascular risk, obesity, hypoandrogenism, exogenous testosterone
- MeSH terms
- Aging, Androgens, Body Composition, Humans, Male, Testosterone, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.